LAMEA Biochips Market Size, Share & Analysis Report, 2019-2025

LAMEA Biochips Market By Product (DNA Chip, Protein Chip, Lab-on-Chip and Other Products) By Application (Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications)

Published Date: August-2019 | Number of Pages: 87 | Format: PDF | Report ID: KBV-11710

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the LAMEA Biochips Market

Market Report Description

The Latin America, Middle East and Africa Biochips Market would witness market growth of 12.3% CAGR during the forecast period (2019-2025).

In the field of biomedical and biotechnological studies, biochips are becoming increasingly used. As the technology in the sector of medicine progresses, the use of proteomics biochips such as microarrays has been increasing. Low sample consumption and their inclination to miniaturization include the benefits of protein biochips. For example, protein microarrays can simultaneously display multiple proteins, which translate into the ability to process thousands of samples in parallel. For a proteome-wide assessment, this feature of microarrays is essential.

Biomarker and drug discovery are commonly used in proteomics. In addition, the surge in the requirement for personalized disease medicine helps the industry grow. The biochip market is being largely influenced by factors such as increased use of biochips in the treatment and diagnosis of cancer and demand for personally tailored medicine, and rapid technological progress.

Based on Product, the market is segmented into DNA Chip, Protein Chip, Lab-on-Chip and Other Products. Based on Application, the market is segmented into Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Click Here For Free Insights

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Horiba Ltd., PerkinElmer, Inc., OriGene Technologies, Inc., Dynamic Biosensors GmbH, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Limited, Thermo Fisher Scientific, Inc.

Scope of the Biochips Market Analysis

Market Segmentation:

ByProduct

  • DNA Chip
  • Protein Chip
  • Lab-on-Chip and
  • Other Products

By Application

  • Drug Discovery and Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • Agriculture and
  • Other Applications

By End User

  • Biotechnology and Pharmaceutical Sector
  • Hospitals and Diagnostics Centers
  • Academic and Research Institutes and
  • Other End Users

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Fluidigm Corporation
  • Horiba Ltd.
  • PerkinElmer, Inc.
  • OriGene Technologies, Inc.
  • Dynamic Biosensors GmbH
  • Illumina, Inc.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Thermo Fisher Scientific, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Biochips Market Related Reports:

Global Market

North America Market

Europe Market

Asia Pacific Market

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities